(Massachusetts General Hospital) Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2Obtb08
No comments:
Post a Comment